Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

NCT00054795 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

550

Enrollment

INDUSTRY

Sponsor class

Conditions

Brain Neoplasms
Carcinoma, Non-Small-Cell Lung
Metastases, Neoplasm

Interventions

DRUG: Motexafin Gadolinium

Sponsor

Pharmacyclics LLC.